Lung Teofil, Tăşcău Oana Cristina, Almăşan Horea Artimoniu, Mureşan Ovidiu
Department of Oral and Maxillofacial Surgery, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.
J Craniomaxillofac Surg. 2007 Mar;35(2):126-31. doi: 10.1016/j.jcms.2007.02.002. Epub 2007 Apr 20.
In the second part of an analysis of a 10-year period of treating oral cancer patients, the focus was the efficiency of treatment, recurrence rates and survival.
From 1485 patients with oral and maxillofacial malignant tumours, 1072 cases could be evaluated. The following data were analyzed statistically: patients' charts and medical records including the follow-up reports.
From all patients studied, 811 underwent surgical treatment alone, the mean recurrence rate was 23%. The recurrence rate after surgery plus radiotherapy was 38%; after surgical treatment alone it was 23%; the survival rate at 3 and 5 years post-therapeutically was 49% and 31%, respectively.
The first choice therapy for carcinomas is surgical. The recurrence rate increased with lymph node involvement and tumour size.
在对口腔癌患者进行的为期10年治疗分析的第二部分中,重点是治疗效率、复发率和生存率。
在1485例口腔颌面恶性肿瘤患者中,1072例可进行评估。对以下数据进行了统计分析:患者病历及医疗记录,包括随访报告。
在所有研究患者中,811例仅接受了手术治疗,平均复发率为23%。手术加放疗后的复发率为38%;单纯手术治疗后的复发率为23%;治疗后3年和5年的生存率分别为49%和31%。
癌症的首选治疗方法是手术。复发率随淋巴结受累情况和肿瘤大小增加而升高。